If solution with particulates is administered, the particulates could pass through the catheter and lead to local inflammation, mechanical disruption of tissue or an immune response to the particulate. In some cases, it may cause a delay in therapy.
Hospira has not received any adverse events reports associated with this issue.
More Articles on Recalls:
What the Increase in Device Recalls Means for Hospitals
14 Device Recalls in 2014
Medical Device Recalls Increased 97% Over Past 10 Years
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
